Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene
- 15 August 2006
- journal article
- Published by Wiley in Haemophilia
- Vol. 12 (5), 479-489
- https://doi.org/10.1111/j.1365-2516.2006.01303.x
Abstract
Summary. Inherited factor X deficiency (FXD) is a rare (1:1 000 000) recessive bleeding disorder. The clinical and laboratory phenotypes of FXD are poorly correlated and few regional studies on the genotype and the clinical manifestations of FXD are known. To understand the association between clinical manifestations and causative genotype, detailed evaluation of bleeding pattern in a high number of patients is needed. This international study analysed the phenotype and genotype of 102 subjects from Central Europe (Germany, Poland and Slovakia) and Latin America (Costa Rica and Venezuela) with causative mutations in the F10 gene, via sequencing. Twenty-eight homozygous, seven compound-heterozygous and 67 heterozygous FXD subjects were characterized. Twenty-nine different causative mutations, including 15 novel mutations, were analysed. Spontaneous bleeding symptoms in 42 symptomatic individuals (26 homozygous, seven compound heterozygous and nine heterozygous) comprised easy bruising (55%), haematoma (43%), epistaxis (36%), haemarthrosis (33%), intracranial haemorrhage (ICH; 21%), and gastrointestinal (GI) haemorrhage (12%). The manifestation of bleeding symptoms in 9 of 67 (13%) symptomatic heterozygous subjects is described. The bleeding patterns of the enrolled patients showed differences that are associated with the types of F10 mutation, and the corresponding genotypes. The homozygous patients were evaluated for genotype–phenotype correlation. The results suggested that ICH seems to be associated with the F10 mutation Gly380Arg, and possibly with the mutations IVS7–1G > A and Tyr163delAT. A tentative association of other mutations to severe symptoms such as haemarthrosis and GI haemorrhage is reported. The severity of FXD, the genotype–phenotype association, and the results of regional studies are discussed.Keywords
This publication has 22 references indexed in Scilit:
- Clinical picture and management of congenital factor VII deficiencyHaemophilia, 2004
- Recessively inherited coagulation disordersBlood, 2004
- Factor X deficiencyBlood Reviews, 2002
- A New Factor X Defect (Factor X Padua 3): A Compound Heterozygous Between True Deficiency (Gly380→Arg) and an Abnormality (Ser334→Pro)Thrombosis Research, 2001
- Molecular Biology and Clinical Manifestation of Hereditary Factor VII DeficiencySeminars in Thrombosis and Hemostasis, 2000
- Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patientsBritish Journal of Haematology, 1998
- Factor X and its deficiency statesHaemophilia, 1997
- Factor X StocktonBlood Coagulation & Fibrinolysis, 1996
- Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domainBritish Journal of Haematology, 1995
- Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion.JCI Insight, 1991